Correlation Between Instil Bio and Vor Biopharma
Can any of the company-specific risk be diversified away by investing in both Instil Bio and Vor Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Instil Bio and Vor Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Instil Bio and Vor Biopharma, you can compare the effects of market volatilities on Instil Bio and Vor Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Instil Bio with a short position of Vor Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Instil Bio and Vor Biopharma.
Diversification Opportunities for Instil Bio and Vor Biopharma
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Instil and Vor is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Instil Bio and Vor Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vor Biopharma and Instil Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Instil Bio are associated (or correlated) with Vor Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vor Biopharma has no effect on the direction of Instil Bio i.e., Instil Bio and Vor Biopharma go up and down completely randomly.
Pair Corralation between Instil Bio and Vor Biopharma
Considering the 90-day investment horizon Instil Bio is expected to generate 1.32 times more return on investment than Vor Biopharma. However, Instil Bio is 1.32 times more volatile than Vor Biopharma. It trades about 0.04 of its potential returns per unit of risk. Vor Biopharma is currently generating about -0.05 per unit of risk. If you would invest 1,200 in Instil Bio on September 24, 2024 and sell it today you would earn a total of 861.00 from holding Instil Bio or generate 71.75% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Instil Bio vs. Vor Biopharma
Performance |
Timeline |
Instil Bio |
Vor Biopharma |
Instil Bio and Vor Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Instil Bio and Vor Biopharma
The main advantage of trading using opposite Instil Bio and Vor Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Instil Bio position performs unexpectedly, Vor Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vor Biopharma will offset losses from the drop in Vor Biopharma's long position.Instil Bio vs. Fate Therapeutics | Instil Bio vs. Sana Biotechnology | Instil Bio vs. Caribou Biosciences | Instil Bio vs. Arcus Biosciences |
Vor Biopharma vs. Monte Rosa Therapeutics | Vor Biopharma vs. Design Therapeutics | Vor Biopharma vs. Erasca Inc | Vor Biopharma vs. Edgewise Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |